NCT01025479 Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent Status COMPLETED Phase N/A
NCT01020604 PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients Status COMPLETED Phase N/A
NCT01020448 Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE3
NCT01020305 Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01018901 Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment Status COMPLETED Phase NA
NCT01013129 Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer Status COMPLETED Phase N/A
NCT01009736 Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy Status COMPLETED Phase PHASE1/PHASE2
NCT01008969 Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients Status COMPLETED Phase NA
NCT01006564 Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer Status UNKNOWN Phase NA
NCT01006395 Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) Status COMPLETED Phase PHASE2/PHASE3
NCT01000948 A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT00999960 Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator Status TERMINATED Phase NA
NCT00997464 An Exploration of Genetic Testing for Prostate Cancer Susceptibility Status UNKNOWN Phase N/A
NCT00996502 Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00992745 A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer Status COMPLETED Phase PHASE1
NCT00992615 Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer Status COMPLETED Phase NA
NCT00992186 A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer Status COMPLETED Phase PHASE2